Skip to content

BD BBL™ Enriched Thioglycollate Medium 297292Recalls & reported problems

Becton, Dickinson And Company · BD BBL™ Enriched Thioglycollate Medium, 10 mL · Class 1

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 30382902972922), received between Apr 22, 2022 and Apr 22, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Contamination of Device Ingredient or Reagent” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Contamination of Device Ingredient or Reagent1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 22, 2022Contamination of Device Ingredient or Reagent; Contamination of Device Ingredient or Reagent

    IT HAS BEEN REPORTED THAT THE BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN HAS BEEN FOUND EXPERIENCING SEVEN OCCURRENCES OF CONTAINING BIOLOGICAL CONTAMINATION. THE FOLLOWING HAS BEEN PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED THAT THERE IS MOLD INSIDE TUBES AFTER INOCULATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14189959 ↗

Other CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL devices

All CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.